Bortezomib With Melphalan and Prednisone for Multiple Myeloma

Clinical trial NCT00734149 · COMPLETED

Trial details

NCT number: NCT00734149
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2004-07-01
Primary completion: 2008-02-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.